SE406419B - METHOD OF MANUFACTURING AN INJECTIVE WHICH DOES NOT LIPOID A OR ALKALI-TREATED LIPOID - Google Patents

METHOD OF MANUFACTURING AN INJECTIVE WHICH DOES NOT LIPOID A OR ALKALI-TREATED LIPOID

Info

Publication number
SE406419B
SE406419B SE7214629A SE1462972A SE406419B SE 406419 B SE406419 B SE 406419B SE 7214629 A SE7214629 A SE 7214629A SE 1462972 A SE1462972 A SE 1462972A SE 406419 B SE406419 B SE 406419B
Authority
SE
Sweden
Prior art keywords
lipoid
injective
alkali
treated
manufacturing
Prior art date
Application number
SE7214629A
Other languages
Swedish (sv)
Inventor
C Galanos
O Luderitz
O Westphal
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Publication of SE406419B publication Critical patent/SE406419B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1235—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7214629A 1971-11-17 1972-11-10 METHOD OF MANUFACTURING AN INJECTIVE WHICH DOES NOT LIPOID A OR ALKALI-TREATED LIPOID SE406419B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2157148A DE2157148A1 (en) 1971-11-17 1971-11-17 IMMUNIZING PRODUCTS, METHOD OF MANUFACTURING AND ITS USES

Publications (1)

Publication Number Publication Date
SE406419B true SE406419B (en) 1979-02-12

Family

ID=5825419

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7214629A SE406419B (en) 1971-11-17 1972-11-10 METHOD OF MANUFACTURING AN INJECTIVE WHICH DOES NOT LIPOID A OR ALKALI-TREATED LIPOID

Country Status (10)

Country Link
JP (1) JPS5512002B2 (en)
AT (1) AT332539B (en)
BE (1) BE791489A (en)
CH (1) CH588867A5 (en)
DD (1) DD102410A5 (en)
DE (1) DE2157148A1 (en)
FR (1) FR2160542B1 (en)
GB (1) GB1416544A (en)
NL (1) NL7215221A (en)
SE (1) SE406419B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS581801U (en) * 1981-06-29 1983-01-07 日興電機工業株式会社 hydraulic unit
DE3516119A1 (en) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt POLYVALENT HYPERIMMIMMLOBULIN PREPARATE
DE10331974A1 (en) * 2003-07-14 2005-02-17 Uni-Klinikum Schleswig-Holstein Campus Kiel Method of making and using antimicrobial protein-inducing factors
WO2014097154A1 (en) * 2012-12-20 2014-06-26 Zakład Badawczo-Wdrożeniowy Ośrodka Salmonella "Immunolab" Sp. Z O.O. A polyvalent combined immunising and/or therapeutic preparation for use in bacterial infections or food poisoning, particularly salmonellosis, a method for production of this preparation, its use and a vaccine comprising this preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1468630A (en) * 1963-03-14 1967-02-10 Taisho Pharmaceutical Co Ltd Preparation of purified alpha lipid from crude alpha lipid derived from lipopolysaccharides of gram-negative bacteria

Also Published As

Publication number Publication date
FR2160542B1 (en) 1976-04-23
AU4902772A (en) 1974-05-23
GB1416544A (en) 1975-12-03
CH588867A5 (en) 1977-06-15
FR2160542A1 (en) 1973-06-29
DE2157148A1 (en) 1973-05-24
JPS5512002B2 (en) 1980-03-29
JPS4861621A (en) 1973-08-29
NL7215221A (en) 1973-05-21
BE791489A (en) 1973-05-16
ATA975872A (en) 1976-01-15
DD102410A5 (en) 1973-12-12
AT332539B (en) 1976-10-11

Similar Documents

Publication Publication Date Title
SE412345B (en) PROCEDURES FOR THE APPLICATION OF RESISTANT SIGNS OR PATTERNS ON A PURPOSE
SE404804B (en) METHOD OF MAKING 18-METHYL-19-NOR-20-KETOPREGANNER
FI65481B (en) SAETT FOER GJUTNING AV ETT AV BETONG BESTAOENDE ROERSTYCKE
SU441704A3 (en) The method of producing propionxylidide
FI53696C (en) FOERFARANDE FOER ATT BILDA ETT METALLOXIDSKIKT
SE381397B (en) PROCEDURE FOR THE PREPARATION OF AN AROMATING AGENT
SE405254B (en) METHOD OF PREPARING 7-HYDROXY-OSTRATRIENS
SE7309804L (en) METHOD OF PREPARING A SULFURIZED CALCIUM ALKYLPHENOLATE.
SE404528B (en) METHOD OF PRODUCING 1ALFA-HYDROXISTEROIDS
SE406419B (en) METHOD OF MANUFACTURING AN INJECTIVE WHICH DOES NOT LIPOID A OR ALKALI-TREATED LIPOID
SE404360B (en) METHOD OF PRODUCING 2-NITROBENSALDEHYDE
SE391720B (en) METHOD OF PRODUCING PERMANENT EMULSIONS OF EQUIPPED, HIGH VISIBLE ORGANOPOLYSILOXANS
SE7508896L (en) PROCEDURE FOR THE PRODUCTION OF VINCAMIN AND OTHER INDOLAL KALOIDS.
SE402458B (en) METHOD OF MAKING NEW 2-AMINO-6-DIALKYLAMINO-DIHYDROPYRIDINES
SE397190B (en) METHOD OF PREPARING SUBSTITUTED DIBENSOCYCLOHEPTENES
FI55318C (en) KAERL SOM AER AVSETT ATT INNEHAOLLA ETT TRYCKMEDIUM
IT956444B (en) TRACHEAL MASK
SE387944B (en) METHOD OF MAKING XANTON-2-CARBONIC ACID COMPOUNDS
SE384197B (en) PROCEDURE FOR MANUFACTURE OF A STOPPED FOREMAL
SE388068B (en) METHOD OF PRODUCING A PERMANENT MAGNETIC MATERIAL ON THE BASIS OF BERIUM AND / OR STRONTIUM FERRITS AND EV. LEAD
SE383888B (en) PROCEDURE FOR THE PREPARATION OF ALFA (CARBO- (5-INDANYLOXY)) - BENZYLPENICILLIN OR A BASIC SALT thereof
SE405118B (en) METHOD OF PREPARING 2,4-DIAMINO-5-BENZYLPYRIMIDINES
SE399411B (en) METHOD OF PRODUCTING TITANTETRAFLUORIDE
SE394888B (en) METHOD OF PRODUCING ALFA-AMINO-2-HYDROXYPHENYLETIC ACIDS
SE404192B (en) METHOD OF PREPARING 3 BETA-CYCLOALKYLOXY-16 ALFA-CYANOPREGN-5-EN-20-ONERS